From: Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases
No concurrent chemotherapy
With concurrent chemotherapy
P Value
MFS
85.8%
84.5%
0.65
DFS
80.3%
82.6%
0.48
OS
89.2%
89.1%
0.82